# Johnson & Johnson to acquire V-Wave for up to $1.7 billion

Johnson & Johnson has entered into a definitive agreement to acquire V-Wave Ltd., a developer of heart failure treatment devices, for an upfront payment of $600 million plus potential milestone payments up to approximately $1.1 billion. V-Wave's Ventura Interatrial Shunt is designed to treat heart failure.

- Type: Acquisition
- Announced: 2024-08-20
- Where: Israel
- Value: $600.0M
- Status: announced
- Products: Ventura Interatrial Shunt implantable device for heart failure
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Johnson & Johnson](https://endata.com/companies/9845.md) (acquirer)
- [V-Wave Ltd.](https://endata.com/companies/79280.md) (target)

## Sources

- [jnjmedtech.com](https://www.jnjmedtech.com/en-US/news-events/johnson-johnson-acquire-v-wave), 2024-08-20: "The planned acquisition of V-Wave will extend Johnson & Johnson MedTech’s position as an innovation leader in addressing cardiovascular disease."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.